Alamar Biosciences, Inc. (ALMR) vs Privia Health Group, Inc. (PRVA)

A side-by-side comparison of Alamar Biosciences, Inc. and Privia Health Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALMR vs PRVA

growth of $100 · dividends reinvested · last 1y
ALMR +73.3% (+73.3%/yr)PRVA -14.9% (-14.9%/yr)ALMR compounded faster over this window
80100120140160180Start $100$173$85
ALMR PRVA

ALMR vs PRVA: by the numbers

  • •PRVA is the larger company ($2.56B vs $2.24B market cap).
  • •PRVA is profitable (1.19% net margin) while ALMR runs a net loss (-40.18%).

Metrics side by side

Valuation

MetricALMRPRVA
P/E ratioN/A93.50
Forward P/EN/A78.74
P/S ratioN/A1.08
P/B ratio7.150.00

Profitability

MetricALMRPRVA
Gross margin56.20%7.61%
Operating margin-42.22%1.90%
Net margin-40.18%1.19%
ROEN/A0.00%
ROIC-26.95%0.00%

Growth (annualized)

MetricALMRPRVA
Revenue CAGR (5Y)N/A22.35%
EPS CAGR (5Y)N/A-8.73%
Total return CAGR (5Y)N/A-1.30%

Frequently asked

Is ALMR or PRVA more profitable?
PRVA runs the higher net margin — ALMR at -40.18% versus PRVA at 1.19%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.